UNIGE document Doctoral Thesis
previous document  unige:29042  next document
add to browser collection

Application and evaluation of population pharmacokinetics for Imatinib Dosage Individualization

Defense Thèse de doctorat : Univ. Genève, 2013 - Sc. 4561 - 2013/05/08
Abstract Imatinib treatment for chronic myeloid leukemia (CML) could be optimized by Therapeutic Drug Monitoring (TDM). The objective of this thesis was to enhance the clinical interpretation of imatinib concentrations measured in the scope of TDM, to improve the evidence of concentration-response relationships, and to evaluate the usefulness of systematic TDM-guided dosage individualization. For this purpose, the population pharmacokinetic (PPK) approach was used and evaluated in several studies. A reference range of imatinib concentrations over the dosage interval was established through a simulation-based meta-analysis of several PPK models. From a validated in-house PPK model, a Bayesian approach for the prediction of the individual trough concentration (Cmin) was developed and validated. Correlations between individual Cmin and treatment response were confirmed in a large European patient cohort study. The clinical usefulness of systematic TDM was evaluated through a prospective randomized controlled trial. The Bayesian approach allowed easing the sampling logistics in the trial.
Keywords pharmakokineticspharmacodynamicsclinical pharmacologymodelingtyrosine kinase inhibitormonitoring
URN: urn:nbn:ch:unige-290424
Full text
Thesis (24.8 MB) - document accessible for UNIGE members only Limited access to UNIGE
(ISO format)
GOTTA, Verena. Application and evaluation of population pharmacokinetics for Imatinib Dosage Individualization. Université de Genève. Thèse, 2013. doi: 10.13097/archive-ouverte/unige:29042 https://archive-ouverte.unige.ch/unige:29042

464 hits



Deposited on : 2013-08-05

Export document
Format :
Citation style :